The AMA believes physicians should still be the main prescribers, while advocates for provider status for pharmacists say it's a win for health equity and will expand treatment access.
Industry experts from Syneos and Medable will share their perspectives on how to address these drug development challenges within cardiometabolic clinical studies and provide input on the impact of new regulatory guidance such as the DEPICT Act.
This engaging panel will discuss leveraging technology and home health solutions to augment existing points of care between patients and their clinical care team to improve the patient experience, drive more scientific rigor to data generation and achieve timely endpoint capture.
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. Don't miss your chance to save with the Super Early Bird Rate.
Most federally qualified health centers are committed to remaining independent of hospital affiliation. In order to maintain their independence, it is critical that FQHCs face work together more closely on data pooling and and sharing best practices for improving community health, according to a recent report.
AbbVie paid Alector $225 million up front five years ago to begin an R&D partnership on two drugs intended to bring an immunotherapy approach to the treatment of Alzheimer's disease. One of the drugs has reached Phase 2 testing but the pharmaceutical giant has terminated the alliance on a program in Phase 1.
By Smriti Kirubanandan Friday, July 8, 2022 10:00 AM
While there is a heightened awareness about closing the gaps in the system and creating equality, one of the influential groups that suffer from this injustice is the LGBTQ community.
Replace the tedious manual resume screening process! Learn how AI frameworks and technology are streamlining the recruiter/candidate experience, resulting in healthcare industries hiring skilled and knowledgeable personnel quickly and effectively.
No comments